MARATTO

preprint · F1000Research

Case Report: Case report: An unusual presentation of granulomatosis with polyangiitis

Abstract

<ns4:p> <ns4:bold>Aim:</ns4:bold> We are reporting a case of an unusual presentation of granulomatosis with polyangiitis (GPA) with liver involvement. <ns4:bold>Case presentation:</ns4:bold> A 45-year-old male patient presented with erythematous plaques on the face and bilateral nasal obstruction. On physical examination, the patient had a ring-shaped squamous plaque on the face. The laboratory findings revealed an accelerated erythrocyte sedimentation rate at 100 mm/h, an elevated C-reactive protein at 66 mg/L, hyper gamma globulinemia 16 g/L and an elevated alkaline phosphatase (twice the upper normal limit). The craniofacial and thoracoabdominal computed tomography (CT) -scans showed ethmoid and maxillary sinusitis, low facial bone density, multiple mediastinal and hilar lymphadenopathy, diffuse small pulmonary nodules, and hepatomegaly. A cutaneous lesion biopsy, the nasal mucosa, and the liver showed a chronic inflammatory granulomatosis process with necrosis. Serum anti-neutrophil cytoplasmic antibody (ANCA) against PR3 was positive. The clinical, biological, radiological, and histological findings substantiated the diagnosis of GPA. The patient received systemic steroids combined with cyclophosphamide pulses on days 1, 14 and 28 and then he was lost to follow-up. Two-years later, he presented with a cardiac failure and skin ulcer in the right lower limb. A nasal endoscopic exam showed nasal septum cartilage perforation with resorption of the middle and inferior nasal concha. Two weeks later, he developed a diffuse alveolar hemorrhage and was therefore transferred to the intensive care unit but died of respiratory failure 3 days later. <ns4:bold>Conclusion:</ns4:bold> Clinicians should be aware of GPA atypical clinical manifestations. </ns4:p>

Research topics

  • Vasculitis and related conditions
  • Sarcoidosis and Beryllium Toxicity Research
  • IgG4-Related and Inflammatory Diseases

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.12688/f1000research.133102.5

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.